{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T15:56:54Z","timestamp":1674575814891},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T00:00:00Z","timestamp":1345075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00115-011-3446-9","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T12:18:31Z","timestamp":1345033111000},"page":"1128-1141","source":"Crossref","is-referenced-by-count":7,"title":["Psychopharmakotherapeutische Ans\u00e4tze bei somatoformen St\u00f6rungen und funktionellen K\u00f6rpersyndromen"],"prefix":"10.1007","volume":"83","author":[{"given":"H.P.","family":"Kapfhammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,16]]},"reference":[{"key":"3446_CR1","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3748\/wjg.15.3636","volume":"15","author":"Abdul-Baki","year":"2009","unstructured":"Abdul-Baki H, El Hajj II, Elzahabi L et al (2009) A randomized controlled trial of imipramine in patients with irritable bowel syndrome. World J Gastroenterol 15:3636\u20133642","journal-title":"World J Gastroenterol"},{"key":"3446_CR2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S1092852900016291","volume":"13","author":"Allen","year":"2008","unstructured":"Allen A, Hadley SJ, Kaplan A et al (2008) An open-label trial of venlafaxine in body dysmorphic disorder. CNS Spectr 13:138\u2013144","journal-title":"CNS Spectr"},{"key":"3446_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2007.07.019","volume":"32","author":"Amsterdam","year":"2008","unstructured":"Amsterdam JD, Shults J, Rutherford N (2008) Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:100\u2013106","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3446_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpain.2004.03.003","volume":"9","author":"Aragona","year":"2005","unstructured":"Aragona M, Bancheri L, Perinelli D et al (2005) Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. Eur J Pain 9:33\u201338","journal-title":"Eur J Pain"},{"key":"3446_CR5","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3899\/jrheum.100365","volume":"37","author":"Arnold","year":"2010","unstructured":"Arnold LM, Clauw D, Wang F et al (2010) Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 37:2578\u20132586","journal-title":"J Rheumatol"},{"key":"3446_CR6","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/art.27559","volume":"62","author":"Arnold","year":"2010","unstructured":"Arnold LM, Gendreau RM, Palmer RH et al (2010) Efficacy and safety of milnacipran 100\u00a0mg\/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62:2745\u20132756","journal-title":"Arthritis Rheum"},{"key":"3446_CR7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/appi.psy.41.2.104","volume":"41","author":"Arnold","year":"2000","unstructured":"Arnold LM, Keck PE, Welge JA (2000) Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41:104\u2013113","journal-title":"Psychosomatics"},{"key":"3446_CR8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1176\/appi.psy.51.6.489","volume":"51","author":"Arnold","year":"2010","unstructured":"Arnold LM, Leon T, Whalen E, Barrett J (2010) Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia. Psychosomatics 51:489\u2013497","journal-title":"Psychosomatics"},{"key":"3446_CR9","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"Arnold","year":"2004","unstructured":"Arnold LM, Lu Y, Crofford LJ et al (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50:2974\u20132984","journal-title":"Arthritis Rheum"},{"key":"3446_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","volume":"119","author":"Arnold","year":"2005","unstructured":"Arnold LM, Rosen A, Pritchett YL et al (2005) A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119:5\u201315","journal-title":"Pain"},{"key":"3446_CR11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","volume":"9","author":"Arnold","year":"2008","unstructured":"Arnold LM, Russell IJ, Diri EW, Duan WR et al (2008) A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 9:792\u2013805","journal-title":"J Pain"},{"key":"3446_CR12","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar3359","volume":"13","author":"Arnold","year":"2011","unstructured":"Arnold LM, Wang F, Ahl J et al (2011) Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial. Arthritis Res Ther 13:R86","journal-title":"Arthritis Res Ther"},{"key":"3446_CR13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jpeds.2007.10.012","volume":"152","author":"Bahar","year":"2008","unstructured":"Bahar RJ, Collins BS, Steinmetz B, Ament ME (2008) Double-blind, placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr 152:685\u2013689","journal-title":"J Pediatr"},{"key":"3446_CR14","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1212\/01.WNL.0000127282.90920.8C","volume":"62","author":"Bendtsen","year":"2004","unstructured":"Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62:1706\u20131711","journal-title":"Neurology"},{"key":"3446_CR15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.61.3.285","volume":"61","author":"Bendtsen","year":"1996","unstructured":"Bendtsen L, Jensen R, Olesen J (1996) A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 61:285\u2013290","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3446_CR16","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.amjmed.2005.07.047","volume":"119","author":"Blockmans","year":"2006","unstructured":"Blockmans D, Persoons P, Houdenhove B van, Bobbaers H (2006) Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med 119:e23\u2013e30","journal-title":"Am J Med"},{"key":"3446_CR17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3899\/jrheum.101025","volume":"38","author":"Branco","year":"2011","unstructured":"Branco JC, Cherin P, Montagne A et al (2011) Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study. J Rheumatol 38:1403\u20131412","journal-title":"J Rheumatol"},{"key":"3446_CR18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3899\/jrheum.090884","volume":"37","author":"Branco","year":"2010","unstructured":"Branco JC, Zachrisson O, Perrot S, Mainguy Y et al (2010) A European multicenter randomized double-blind, placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol 37:851\u2013859","journal-title":"J Rheumatol"},{"key":"3446_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archinte.161.3.411","volume":"161","author":"Breitbart","year":"2001","unstructured":"Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J (2001) A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 161:411\u2013420","journal-title":"Arch Intern Med"},{"key":"3446_CR20","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1200\/JCO.2005.02.8506","volume":"24","author":"Bruera","year":"2006","unstructured":"Bruera B, Valcro V, Driver L et al (2006) Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073\u20132078","journal-title":"J Clin Oncol"},{"key":"3446_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AJP.0b013e31819be587","volume":"25","author":"Chappell","year":"2009","unstructured":"Chappell AS, Littlejohn G, Kajdasz DK et al (2009) A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia. Clin J Pain 25:365\u2013375","journal-title":"Clin J Pain"},{"key":"3446_CR22","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.clinthera.2008.11.009","volume":"30","author":"Clauw","year":"2008","unstructured":"Clauw DJ, Mease P, Palmer RH et al (2008) Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 30:1988\u20132004","journal-title":"Clin Ther"},{"key":"3446_CR23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/gast.2003.50055","volume":"124","author":"Creed","year":"2003","unstructured":"Creed F, Fernandes L, Guthrie E et al (2003) The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124:303\u2013317","journal-title":"Gastroenterology"},{"key":"3446_CR24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/j.1440-1614.2005.01686.x","volume":"39","author":"Creed","year":"2005","unstructured":"Creed F, Guthrie E, Ratcliffe J, Fernandes L et al (2005) Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? Aust N Z J Psychiatry 39:807\u2013815","journal-title":"Aust N Z J Psychiatry"},{"key":"3446_CR25","doi-asserted-by":"crossref","unstructured":"Creed F, Henningsen P, Fink P (Hrsg) (2011) Medically unexplained symptoms, somatization and bodils distress. Developing better clinical services. Cambridge University Press, Cambridge","DOI":"10.1017\/CBO9780511977862"},{"key":"3446_CR26","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","volume":"52","author":"Crofford","year":"2005","unstructured":"Crofford LJ, Rowbotham MC, Mease PJ et al (2005) Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52:1264\u20131273","journal-title":"Arthritis Rheum"},{"key":"3446_CR27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1192\/bjp.184.6.470","volume":"184","author":"De","year":"2004","unstructured":"De Waal MWM, Arnold IA, Eekhof JAH, Van Hemert AM (2004) Somatoform disorders in general practice prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 184:470\u2013476","journal-title":"Br J Psychiatry"},{"key":"3446_CR28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1891\/0889-8391.22.2.115","volume":"22","author":"Deacon","year":"2008","unstructured":"Deacon B, Abramowitz JS (2008) Is hypochondriasis related to obsessive-compulsive disorder, panic disorder, or both? An empirical evaluation. J Cogn Psychother 22:115\u2013127","journal-title":"J Cogn Psychother"},{"key":"3446_CR29","first-page":"15","volume":"39","author":"Doraiswamy","year":"2006","unstructured":"Doraiswamy PM, Varia I, Hellegers C et al (2006) A randomized controlled trial of paroxetine for noncardiac chest pain. Psychopharmacol Bull 39:15\u201324","journal-title":"Psychopharmacol Bull"},{"key":"3446_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","volume":"125","author":"Drossman","year":"2003","unstructured":"Drossman DA, Toner BB, Whitehead WE et al (2003) Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 125:19\u201331","journal-title":"Gastroenterology"},{"key":"3446_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-3999(97)00215-8","volume":"44","author":"Engel","year":"1998","unstructured":"Engel CC, Walker EA, Engel AL et al (1998) A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res 44:203\u2013207","journal-title":"J Psychosom Res"},{"key":"3446_CR32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/JCP.0b013e31818d21cf","volume":"28","author":"Fallon","year":"2008","unstructured":"Fallon BA, Petkova E, Skritskaya N et al (2008) A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. J Clin Psychopharmacol 28:638\u2013645","journal-title":"J Clin Psychopharmacol"},{"key":"3446_CR33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1176\/appi.psy.44.4.298","volume":"44","author":"Fallon","year":"2003","unstructured":"Fallon BA, Quereshi AI, Schneier FR et al (2003) An open trial of fluvoxamie for hypochondriasis. Psychosomatics 44:298\u2013303","journal-title":"Psychosomatics"},{"key":"3446_CR34","first-page":"1","volume":"21","author":"Farber","year":"2001","unstructured":"Farber L, Stratz TH, Sp\u00e4th M et al (2001) Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. Int J Clin Pharmacol Res 21:1\u201313","journal-title":"Int J Clin Pharmacol Res"},{"key":"3446_CR35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006842-199807000-00019","volume":"60","author":"Fishbain","year":"1998","unstructured":"Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS (1998) Do antidepressants have an analgetic effect in psychogenic pain and somatoform pain disorder? A meta-analysis. Psychosom Med 60:503\u2013509","journal-title":"Psychosom Med"},{"key":"3446_CR36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0163-8343(02)00205-0","volume":"24","author":"Garcia-Campayo","year":"2002","unstructured":"Garcia-Campayo J, Sanz-Carrillo C (2002) Topiramate as a treatment for pain in multisomatoform disorder patients:An open trial. Gen Hosp Psychiatry 24:417\u2013421","journal-title":"Gen Hosp Psychiatry"},{"key":"3446_CR37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1533-2500.2010.00403.x","volume":"11","author":"Geisser","year":"2011","unstructured":"Geisser ME, Palmer RH, Gendreau RM et al (2011) A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia. Pain Pract 11:120\u2013131","journal-title":"Pain Pract"},{"key":"3446_CR38","first-page":"13","volume":"54","author":"Goodnick","year":"1993","unstructured":"Goodnick PJ, Sandoval R (1993) Psychotropic treatment of chronic fatigue syndrome and related disorders. J Clin Psychiatry 54:13\u201320","journal-title":"J Clin Psychiatry"},{"key":"3446_CR39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jbtep.2009.06.005","volume":"40","author":"Greeven","year":"2009","unstructured":"Greeven A, Balkom AJ van, Leeden R van der et al (2009) Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up. J Behav Ther Exp Psychiatry 40:487\u2013496","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"3446_CR40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1176\/appi.ajp.164.1.91","volume":"164","author":"Greeven","year":"2007","unstructured":"Greeven A, Balkom AJ van, Visser S et al (2007) Cognitive behaviour therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry 164:91\u201399","journal-title":"Am J Psychiatry"},{"key":"3446_CR41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2710.2008.00975.x","volume":"34","author":"Han","year":"2009","unstructured":"Han C, Masand PS, Krulewicz S, Peindl K et al (2009) Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release. J Clin Pharm Ther 34:79\u201388","journal-title":"J Clin Pharm Ther"},{"key":"3446_CR42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.pnpbp.2007.09.014","volume":"32","author":"Han","year":"2008","unstructured":"Han C, Pae CU, Lee BH, Ko YH et al (2008) Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trial. Prog Neuropsychopharmacol Biol Psychiatry 32:437\u2013444","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3446_CR43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00044011-200828040-00006","volume":"28","author":"Han","year":"2008","unstructured":"Han C, Pae CU, Lee BH, Ko YH et al (2008) Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial. Clin Drug Investig 28:251\u2013261","journal-title":"Clin Drug Investig"},{"key":"3446_CR44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/JCP.0b013e31814e5e84","volume":"27","author":"Harnack","year":"2007","unstructured":"Harnack D, Scheel M, Mundt A, Kupsch A et al (2007) Pregabalin in patients with antidepressant treatment-resistant somatoform disorders: a case series. J Clin Psychopharmacol 27:537\u2013539","journal-title":"J Clin Psychopharmacol"},{"key":"3446_CR45","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4088\/JCP.v64n0811","volume":"64","author":"Hartz","year":"2003","unstructured":"Hartz AJ, Bentler SE, Brake KA, Kelly MW (2003) The effectiveness of citalopram for idiopathic chronic fatigue. J Clin Psychiatry 64:927\u2013935","journal-title":"J Clin Psychiatry"},{"key":"3446_CR46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2008.944","volume":"301","author":"H\u00e4user","year":"2009","unstructured":"H\u00e4user W, Bernardy K, Uccyler N, Sommer C (2009) Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 301:198\u2013209","journal-title":"JAMA"},{"key":"3446_CR47","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(07)60159-7","volume":"396","author":"Henningsen","year":"2007","unstructured":"Henningsen P, Zipfel S, Herzog W (2007) Management of functional somatic syndromes. Invited review. Lancet 396:946\u2013955","journal-title":"Lancet"},{"key":"3446_CR48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0889-857X(01)00013-8","volume":"28","author":"Henriksson","year":"2002","unstructured":"Henriksson KG, Sorensen J (2002) The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia. Rheum Dis Clin North Am 28:343\u2013351","journal-title":"Rheum Dis Clin North Am"},{"key":"3446_CR49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4088\/JCP.v61n0909","volume":"61","author":"Hickie","year":"2000","unstructured":"Hickie IB, Wilson AJ, Wright JM et al (2000) A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry 61:643\u2013648","journal-title":"J Clin Psychiatry"},{"key":"3446_CR50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archpsyc.56.11.1033","volume":"56","author":"Hollander","year":"1999","unstructured":"Hollander E, Allen A, Kwon Jee BA et al (1999) Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 56:1033\u20131039","journal-title":"Arch Gen Psychiatry"},{"key":"3446_CR51","first-page":"CD005332","volume":"21","author":"Ipser","year":"2009","unstructured":"Ipser JC, Sander C, Stein DJ (2009) Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database Syst Rev 21:CD005332","journal-title":"Cochrane Database Syst Rev"},{"key":"3446_CR52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","volume":"108","author":"Jackson","year":"2000","unstructured":"Jackson JL, O\u2019Malley G, Balden E et al (2000) Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 108:65\u201372","journal-title":"Am J Med"},{"key":"3446_CR53","doi-asserted-by":"crossref","unstructured":"Kapfhammer HP (2012) Somatoforme St\u00f6rungen und Somatisierungssyndrome. In: Gr\u00fcnder G, Benkert O (Hrsg) Handbuch der Psychopharmakotherapie, 2. Aufl. Springer, Berlin, S\u00a01043\u20131057","DOI":"10.1007\/978-3-642-19844-1_81"},{"key":"3446_CR54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpainsymman.2011.03.026","volume":"43","author":"Kerr","year":"2012","unstructured":"Kerr CW, Drake J, Milch RA, Brazeau DA et al (2012) Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 43:68\u201377","journal-title":"J Pain Symptom Manage"},{"key":"3446_CR55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4088\/JCP.v67n0111","volume":"67","author":"Kroenke","year":"2006","unstructured":"Kroenke K, Messina N 3rd, Benattia I, Graepel J et al (2006) Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder. J Clin Psychiatry 67:72\u201380","journal-title":"J Clin Psychiatry"},{"key":"3446_CR56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1542-3565(03)70039-1","volume":"1","author":"Kuiken","year":"2003","unstructured":"Kuiken SD, Tytgat GN, Boeckxstaens GE (2003) The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 1:219\u2013228","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3446_CR57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cgh.2009.09.008","volume":"8","author":"Ladabaum","year":"2010","unstructured":"Ladabaum U, Sharabidze A, Levin TR et al (2010) Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 8:42\u201348, e1","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3446_CR58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1468-2982.2008.01720.x","volume":"29","author":"Lindelof","year":"2009","unstructured":"Lindelof K, Bendtsen L (2009) Memantine for prophylaxis of chronic tension-type headache\u2014a double-blind, randomized, crossover clinical trial. Cephalalgia 29:314\u2013321","journal-title":"Cephalalgia"},{"key":"3446_CR59","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.pnpbp.2009.08.013","volume":"33","author":"Luo","year":"2009","unstructured":"Luo YL, Zhang MY, Wu WY, Li CB et al (2009) A randomized, double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder. Prog Neuropsychopharmacol Biol Psychiatry 33:1522\u20131525","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3446_CR60","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11894-010-0124-1","volume":"12","author":"Manabe","year":"2010","unstructured":"Manabe N, Rao AS, Wong BS, Camilleri M (2010) Emerging pharmacologic therapies for irritable bowel syndrome. Curr Gastroenterol Rep 12:408\u2013416","journal-title":"Curr Gastroenterol Rep"},{"key":"3446_CR61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.psy.50.1.78","volume":"50","author":"Masand","year":"2009","unstructured":"Masand PS, Pae CU, Krulewicz et al (2009) A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. Psychosomatics 50:78\u201386","journal-title":"Psychosomatics"},{"key":"3446_CR62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-1999-7958","volume":"32","author":"Maurer","year":"1999","unstructured":"Maurer I, Volz HP, Sauer H (1999) Gabapentin leads to remission of somatoform pain disorder with major depression. Pharmacopsychiatry 32:255\u2013257","journal-title":"Pharmacopsychiatry"},{"key":"3446_CR63","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3899\/jrheum.080734","volume":"36","author":"Mease","year":"2009","unstructured":"Mease PJ, Clauw DJ, Gendreau RM, Rao SG et al (2009) The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 36:398\u2013409","journal-title":"J Rheumatol"},{"key":"3446_CR64","first-page":"502","volume":"35","author":"Mease","year":"2008","unstructured":"Mease PJ, Russell IJ, Arnold LM, Florian H et al (2008) A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 35:502\u2013514","journal-title":"J Rheumatol"},{"key":"3446_CR65","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.semarthrit.2008.11.001","volume":"39","author":"Mease","year":"2010","unstructured":"Mease PJ, Russell IJ, Kajdasz DK et al (2010) Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum 39:454\u2013465","journal-title":"Semin Arthritis Rheum"},{"key":"3446_CR66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.1997.tb00277.x","volume":"96","author":"Mitsikostas","year":"1997","unstructured":"Mitsikostas DD, Gatzonis S, Thomas A, Ilias A (1997) Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 96:247\u2013251","journal-title":"Acta Neurol Scand"},{"key":"3446_CR67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/YIC.0b013e32825ea301","volume":"23","author":"Muller","year":"2008","unstructured":"Muller JE, Wentzel I, Koen L, Niehaus DJ et al (2008) Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial. Int Clin Psychopharmacol 23:43\u201348","journal-title":"Int Clin Psychopharmacol"},{"key":"3446_CR68","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.psy.0000128900.13711.5b","volume":"66","author":"M\u00fcller","year":"2004","unstructured":"M\u00fcller T, Mannel M, Murck H, Rahlfs VW (2004) Treatment of somatoform disorders with St. John\u2019s wort: a randomized, double-blind and placebo-controlled trial. Psychosom Med 66:538\u2013547","journal-title":"Psychosom Med"},{"key":"3446_CR69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000026494","volume":"37","author":"Natelson","year":"1998","unstructured":"Natelson BH, Cheu J, Hill N et al (1998) Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome. NeuropsychoBiology 37:150\u2013154","journal-title":"NeuropsychoBiology"},{"key":"3446_CR70","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1525-1497.2000.06279.x","volume":"15","author":"O","year":"2000","unstructured":"O\u2019Malley PG, Balden E, Tomkins G et al (2000) Treatment of fibromyalgia with antidepressants. A meta-analysis. J Gen Intern Med 15:659\u2013666","journal-title":"J Gen Intern Med"},{"key":"3446_CR71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1176\/appi.psy.44.1.38","volume":"44","author":"Olson","year":"2003","unstructured":"Olson LG, Ambrogettti A, Sutherland DC (2003) A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome. Psychosomatics 44:38\u201343","journal-title":"Psychosomatics"},{"key":"3446_CR72","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0278-5846(01)00177-4","volume":"25","author":"Oosterbaan","year":"2001","unstructured":"Oosterbaan DB, Van Balkom AJLM, Van Boeijen C et al (2001) An open study of paroxetine in hypochondriasis. Prog Neuropsychopharmacol Biol Psychiatry 25:1023\u20131033","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3446_CR73","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/14656560902988510","volume":"10","author":"Pae","year":"2009","unstructured":"Pae CU, Marks DM, Patkar AA et al (2009) Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opin Pharmacother 10:1561\u20131570","journal-title":"Expert Opin Pharmacother"},{"key":"3446_CR74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/15622970902789155","volume":"10","author":"Pae","year":"2009","unstructured":"Pae CU, Masand PS, Marks DM et al (2009) History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release. World J Biol Psychiatry 10:435\u2013441","journal-title":"World J Biol Psychiatry"},{"key":"3446_CR75","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.euroneuro.2010.10.008","volume":"21","author":"Pardini","year":"2011","unstructured":"Pardini M, Guida S, Primavera A et al (2011) Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study. Eur Neuropsychopharmacol 21:282\u2013286","journal-title":"Eur Neuropsychopharmacol"},{"key":"3446_CR76","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.amjmed.2006.06.006","volume":"120","author":"Patkar","year":"2007","unstructured":"Patkar AA, Masand PS, Krulewicz S, Mannelli P et al (2007) A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med 120:448\u2013454","journal-title":"Am J Med"},{"key":"3446_CR77","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3899\/jrheum.110569","volume":"38","author":"Pauer","year":"2011","unstructured":"Pauer L, Winkelmann A, Arsenault P, Jespersen A et al (2011) An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol 38:2643\u20132652","journal-title":"J Rheumatol"},{"key":"3446_CR78","first-page":"18","volume":"64","author":"Phillips","year":"2000","unstructured":"Phillips KA (2000) Body dysmorphic disorder: diagnostic controversies and treatment challenges. Bull Menninger Clin 64:18\u201335","journal-title":"Bull Menninger Clin"},{"key":"3446_CR79","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.162.2.377","volume":"162","author":"Phillips","year":"2005","unstructured":"Phillips KA (2005) Placebo-controlled trial of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry 162:377\u2013379","journal-title":"Am J Psychiatry"},{"key":"3446_CR80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.yic.0000194378.65460.ef","volume":"21","author":"Phillips","year":"2006","unstructured":"Phillips KA (2006) An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol 21:177\u2013179","journal-title":"Int Clin Psychopharmacol"},{"key":"3446_CR81","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archpsyc.59.4.381","volume":"59","author":"Phillips","year":"2002","unstructured":"Phillips KA, Albertini RS, Rasmussen SA (2002) A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 59:381\u2013388","journal-title":"Arch Gen Psychiatry"},{"key":"3446_CR82","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4088\/JCP.v62n0910","volume":"62","author":"Phillips","year":"2001","unstructured":"Phillips KA, Albertini RS, Siniscalchi JM et al (2001) Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. J Clin Psychiatry 62:721\u2013727","journal-title":"J Clin Psychiatry"},{"key":"3446_CR83","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1176\/appi.ajp.2008.08040500","volume":"165","author":"Phillips","year":"2008","unstructured":"Phillips KA, Didie ER, Feusner J, Wilhelm S (2008) Body dysmorphic disorder: treating an unrecognized disorder. Am J Psychiatry 165:1111\u20131118","journal-title":"Am J Psychiatry"},{"key":"3446_CR84","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4088\/JCP.v59n0404","volume":"59","author":"Phillips","year":"1998","unstructured":"Phillips KA, Dwight MM, McElroy SL (1998) Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 59:165\u2013171","journal-title":"J Clin Psychiatry"},{"key":"3446_CR85","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/YIC.0b013e32831db2e9","volume":"24","author":"Phillips","year":"2009","unstructured":"Phillips KA, Kelly MM (2009) Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder. Int Clin Psychopharmacol 24:26\u201328","journal-title":"Int Clin Psychopharmacol"},{"key":"3446_CR86","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4088\/JCP.v62n0203","volume":"62","author":"Phillips","year":"2001","unstructured":"Phillips KA, McElroy SL, Dwight MM et al (2001) Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 62:87\u201391","journal-title":"J Clin Psychiatry"},{"key":"3446_CR87","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4088\/JCP.v64n0615","volume":"64","author":"Phillips","year":"2003","unstructured":"Phillips KA, Najjar F (2003) An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry 64:715\u2013720","journal-title":"J Clin Psychiatry"},{"key":"3446_CR88","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2007.04.003","volume":"31","author":"Politi","year":"2007","unstructured":"Politi P, Emanuele E (2007) Successful treatment of refractory hypochondriasis with duloxetine. Prog Neuropsychopharmacol Biol Psychiatry 31:1145\u20131146","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3446_CR89","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0269881105056531","volume":"19","author":"Randall","year":"2005","unstructured":"Randall DC, Cafferty FH, Shneerson JM et al (2005) Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome. J Psychopharmacol 19:647\u2013660","journal-title":"J Psychopharmacol"},{"key":"3446_CR90","first-page":"182","volume":"25","author":"Rossini","year":"2007","unstructured":"Rossini M, Di Munno O, Valentini G, Bianchi G et al (2007) Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients. Clin Exp Rheumatol 25:182\u2013188","journal-title":"Clin Exp Rheumatol"},{"key":"3446_CR91","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/147323000102900407","volume":"29","author":"Rouillon","year":"2001","unstructured":"Rouillon F, Rahola G, Van Moffaert M, Lopes RG et al (2001) Sulpiride in the treatment of somatoform disorders: results of a European observational study to characterize the responder profile. J Int Med Res 29:304\u2013313","journal-title":"J Int Med Res"},{"key":"3446_CR92","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0889-857X(01)00006-0","volume":"28","author":"Russell","year":"2002","unstructured":"Russell IJ (2002) The promise of substance P inhibitors in fibromylagia. Rheum Dis Clin North Am 28:329\u2013342","journal-title":"Rheum Dis Clin North Am"},{"key":"3446_CR93","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR et al (2008) Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136:432\u2013444","journal-title":"Pain"},{"key":"3446_CR94","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ajg.2009.577","volume":"105","author":"Saito","year":"2010","unstructured":"Saito YA, Rey E, Almazar-Elder AE, Harmsen WS et al (2010) A randomized, double-blind, placebo-controlled trial of St John\u2019s wort for treating irritable bowel syndrome. Am J Gastroenterol 105:170\u2013177","journal-title":"Am J Gastroenterol"},{"key":"3446_CR95","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000085207","volume":"51","author":"Saletu","year":"2005","unstructured":"Saletu B, Prause W, Anderer P, Mandl M et al (2005) Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24\u2009\u00d7\u20097 and the Siesta database. Neuropsychobiology 51:148\u2013163","journal-title":"Neuropsychobiology"},{"key":"3446_CR96","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2009.06.060","volume":"137","author":"Saps","year":"2009","unstructured":"Saps M, Youssef N, Miranda A, Nurko S et al (2009) Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology 137:1261\u20131269","journal-title":"Gastroenterology"},{"key":"3446_CR97","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1345\/aph.1D112","volume":"37","author":"Sayar","year":"2003","unstructured":"Sayar K, Aksu G, Ak I, Tosun M (2003) Venlafaxine treatment in fibromyalgia. Ann Pharmacother 37:1561\u20131565","journal-title":"Ann Pharmacother"},{"key":"3446_CR98","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2006-946706","volume":"39","author":"Sch\u00f6nfeldt-Lecuona","year":"2006","unstructured":"Sch\u00f6nfeldt-Lecuona C, Connemann BJ, Wolf RC et al (2006) Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode. Pharmacopsychiatry 39:152\u2013154","journal-title":"Pharmacopsychiatry"},{"key":"3446_CR99","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00482-003-0256-4","volume":"17","author":"Sp\u00e4th","year":"2003","unstructured":"Sp\u00e4th M (2003) Was gibt es Neues in der Therapie der Fibromyalgie? Schmerz 17:437\u2013440","journal-title":"Schmerz"},{"key":"3446_CR100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1192\/bjp.bp.106.031815","volume":"192","author":"Stubhaug","year":"2008","unstructured":"Stubhaug B, Lie SA, Ursin H, Eriksen HR (2008) Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia:randomised placebo-controlled trial. Br J Psychiatry 192:217\u2013223","journal-title":"Br J Psychiatry"},{"key":"3446_CR101","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2004.04127.x","volume":"99","author":"Tabas","year":"2004","unstructured":"Tabas G, Beaves M, Wang J et al (2004) Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial. Am J Gastroenterol 99:914\u2013920","journal-title":"Am J Gastroenterol"},{"key":"3446_CR102","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/gut.2005.077503","volume":"55","author":"Tack","year":"2006","unstructured":"Tack J, Broekaert D, Fischler B, Van Oudenhove L et al (2006) A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 55:1095\u20131103","journal-title":"Gut"},{"key":"3446_CR103","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10620-007-9830-4","volume":"53","author":"Talley","year":"2008","unstructured":"Talley NJ, Kellow JE, Boyce P, Tennant C et al (2008) Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci 53:108\u2013115","journal-title":"Dig Dis Sci"},{"key":"3446_CR104","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4088\/JCP.v63n0905","volume":"63","author":"Turkington","year":"2002","unstructured":"Turkington D, Grant JB, Ferrier IN et al (2002) A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder. J Clin Psychiatry 63:778\u2013781","journal-title":"J Clin Psychiatry"},{"key":"3446_CR105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2036.2005.02566.x","volume":"22","author":"Vahedi","year":"2005","unstructured":"Vahedi H, Merat S, Rashidioon A et al (2005) The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment Pharmacol Ther 22:381\u2013385","journal-title":"Aliment Pharmacol Ther"},{"key":"3446_CR106","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11920-010-0105-y","volume":"12","author":"Van","year":"2010","unstructured":"Van Houdenhove B, Kempke S, Luyten P (2010) Psychiatric aspects of chronic fatigue syndrome and fibromyalgia. Curr Psychiatry Rep 12:208\u2013214","journal-title":"Curr Psychiatry Rep"},{"key":"3446_CR107","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/14656560903487744","volume":"11","author":"Van","year":"2010","unstructured":"Van Houdenhove B, Pae CU, Luyten P (2010) Chronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy? Expert Opin Pharmacother 11:215\u2013223","journal-title":"Expert Opin Pharmacother"},{"key":"3446_CR108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhj.2000.108514","volume":"140","author":"Varia","year":"2000","unstructured":"Varia I, Logue E, O\u2019connor C, Newby K et al (2000) Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 140:367\u2013372","journal-title":"Am Heart J"},{"key":"3446_CR109","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(96)91345-8","volume":"347","author":"Vercoulen","year":"1996","unstructured":"Vercoulen JH, Swanik CM, Zitman FG et al (1996) Randomised double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347:858\u2013861","journal-title":"Lancet"},{"key":"3446_CR110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0924-977X(00)00074-2","volume":"10","author":"Volz","year":"2000","unstructured":"Volz HP, M\u00f6ller HJ, Reimann I, Stoll KD (2000) Opipramol for the treatment of somatoform disorders: results from a placebo-controlled trial. Eur Neuropharmacol 10:211\u2013217","journal-title":"Eur Neuropharmacol"},{"key":"3446_CR111","doi-asserted-by":"crossref","unstructured":"Volz HP, Murck H, Kasper S, M\u00f6ller HJ (2002) St John\u2019s wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial. Psychopharmacology (Berl) 164:294\u2013300","DOI":"10.1007\/s00213-002-1171-6"},{"key":"3446_CR112","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1192\/bjp.172.6.485","volume":"172","author":"Wearden","year":"1998","unstructured":"Wearden AJ, Morriss RK, Mullis R et al (1998) Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 172:485\u2013490","journal-title":"Br J Psychiatry"},{"key":"3446_CR113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3959(91)90007-K","volume":"47","author":"Zitman","year":"1991","unstructured":"Zitman FG, Linssen AC, Edelbroek PM, Van Kempen GM (1991) Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder? Pain 47:25\u201330","journal-title":"Pain"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3446-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-011-3446-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3446-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T17:50:00Z","timestamp":1562089800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-011-3446-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,16]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["3446"],"URL":"https:\/\/doi.org\/10.1007\/s00115-011-3446-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,16]]}}}